6PSK:XETRA:XETRA-Invesco FTSE RAFI Emerging Markets UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 8.597

Change

-0.09 (-1.05)%

Market Cap

USD 0.03B

Volume

19.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.20 (+0.39%)

USD 445.28B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.06 (+0.35%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.07 (+0.26%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.06 (+0.21%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.10 (+0.38%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.26 (+0.56%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

+0.56 (+0.39%)

USD 98.84B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.20 (+0.38%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.07 (+0.06%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.18 (-0.03%)

USD 80.38B

ETFs Containing 6PSK:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.47% 31% F 32% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.47% 31% F 31% F
Trailing 12 Months  
Capital Gain 19.52% 68% D+ 69% C-
Dividend Return 4.06% 83% B 73% C
Total Return 23.58% 76% C+ 75% C
Trailing 5 Years  
Capital Gain 5.25% 36% F 41% F
Dividend Return 18.31% 89% A- 79% B-
Total Return 23.56% 47% F 49% F
Average Annual (5 Year Horizon)  
Capital Gain 5.71% 48% F 49% F
Dividend Return 7.75% 54% F 53% F
Total Return 2.04% 92% A 72% C
Risk Return Profile  
Volatility (Standard Deviation) 12.45% 51% F 60% D-
Risk Adjusted Return 62.25% 52% F 58% F
Market Capitalization 0.03B 17% F 15% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.